Case Report: Integrative Multiomics to Establish Pathogenicity of novel GBE1 R198T Variant
Open Access
- 19 April 2026
- journal article
- Published by F1000 Research Ltd in F1000Research
- Vol. 15, 599
Abstract
Background Glycogen Storage Disease IV (GSD IV) is a rare disease affecting 1 in every 760,000–960,000 live births. GSD IV is caused by mutations in GBE1 , especially if it affects the central catalytic core domain of the glycogen branching enzyme (GBE) protein at 184 th –600 th residue. A novel missense mutation, GBE1 R198T, was detected in a 3-year-old boy in Indonesia. This variant has not previously been reported in allele frequency databases or classified as pathogenic. Method In this study, we used an integrative multi-omics diagnostic approach involving phenotype analysis, proband and trio genetic mutation analysis, protein molecular modeling, protein-ligand docking, and protein expression studies. We compared GBE1 R198T mutation with the wild-type and previously well-known pathogenic variants, L224P and Y329S, to analyze the clinical progression and pathogenic effects of R198T. Results Trio mutation analysis revealed that this mutation was inherited from a heterozygous parent. Functional prediction, molecular modeling, and docking analysis supported the R198T pathomechanism to cause structural changes in the GBE protein domain, which is detrimental to GBE ligand binding with maltoheptose (Glc7). An in vitro study further supported the decrease in GBE1 R198T protein expression compared to that in the WT. In addition, GBE1 R198T band intensity showed similar results to those of the GBE1 L224 variant, indicating potentially similar pathogenic characteristics exhibited by both variants. Conclusions This is the first study to establish the pathogenicity of the GBE1 R198T variant, and the first rare disease functional study reported in Indonesia.Keywords
Funding Information
- Universitas Indonesia (NKB-315/UN2.RST/HKP.05.00/2024)
This publication has 25 references indexed in Scilit:
- Clinical phenotype and trio whole exome sequencing data from a patient with glycogen storage disease IV in IndonesiaData in Brief, 2024
- Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3/BP4 criteriaThe American Journal of Human Genetics, 2022
- A family study implicates GBE1 in the etiology of autism spectrum disorderHuman Mutation, 2021
- Clinical and genetic spectrum of glycogen storage disease in Iranian population using targeted gene sequencingScientific Reports, 2021
- The potential of dietary treatment in patients with glycogen storage disease type IVJournal of Inherited Metabolic Disease, 2020
- The mutational constraint spectrum quantified from variation in 141,456 humansNature, 2020
- Analysis of GBE1 mutations via protein expression studies in glycogen storage disease type IV: A report on a non-progressive form with a literature reviewMolecular Genetics and Metabolism Reports, 2018
- MolProbity: More and better reference data for improved all‐atom structure validationProtein Science, 2017
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- RUBI: rapid proteomic-scale prediction of lysine ubiquitination and factors influencing predictor performanceAmino Acids, 2013